Spots Global Cancer Trial Database for Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults
Official Title: Phase I, Randomized, Controlled, Single-blind, Dose-Ranging and Schedule-Finding Study of the Safety, Tolerability, and Immunogenicity of Chiron Helicobacter Pylori Vaccine in Healthy, Helicobacter Pylori-negative Adults
Study ID: NCT00613665
Study Description
Brief Summary: This study was designed to investigate the safety and immunogenicity of Chiron's investigational H. pylori (HP3) vaccine
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Universitaetsklinikum Charité, Berlin, , Germany
Contact Details
Name: Novartis Vaccines
Affiliation: Novartis Vaccines
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
